Get the Stockscreener App
24.54
2.89%
0.69
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $24.54, with a volume of 6.48M.
It is up +2.89% in the last 24 hours and down -10.80% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$23.85
Open:
$24.1
24h Volume:
6.48M
Relative Volume:
1.11
Market Cap:
$12.60B
Revenue:
$11.89B
Net Income/Loss:
$-560.00M
P/E Ratio:
-22.31
EPS:
-1.1
Net Cash Flow:
$191.00M
1W Performance:
+1.49%
1M Performance:
-10.80%
6M Performance:
-27.44%
1Y Performance:
-32.75%
1-Day Range:
$23.88
$24.61
1-Week Range:
$23.45
$24.89
52-Week Range:
$21.33
$40.49
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
24.54 | 12.13B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
How Hurricanes, Fires and Floods Put Drugs and Medical Supplies at Risk - Bloomberg.com
Options Data Show Bullish Bias in Baxter International Inc.Weekly Stock Analysis & Weekly Top Stock Performers List - beatles.ru
Stock Analysis | Baxter International OutlookMixed Signals as Technical and Analyst Views Diverge - AInvest
Baxter International (NYSE:BAX) Stock Acquired Rep. Lisa C. McClain - MarketBeat
Ligand to Participate in September Investor Conferences - GlobeNewswire Inc.
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Russell Investments Group Ltd. Sells 69,685 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Earnings call transcript: Baxter Q2 2025 misses EPS forecast, stock drops - Investing.com Canada
Surgeons Convene at Vienna Symposium to Experience Baxter's HEMOPATCH Sealing Hemostat - Financial Times
Forsta AP Fonden Sells 188,100 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Baxter's Novum IQ Infusion Pump Safety Crisis: Implications for Medical Device Investors - AInvest
Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 33% Undervaluation? - au.finance.yahoo.com
Trend Dashboard Flags Baxter International Inc. As Potential Swing TradeJuly 2025 Weekly Recap & Real-Time Price Movement Reports - beatles.ru
Baxter downgraded to Hold at Stifel on weak Q2 report - MSN
Baxter International (BAX) Is Up 7.2% After Profitable Q2 and Raised Sales GuidanceWhat's Changed - simplywall.st
Here’s Why You Should Consider Selling Your Baxter (BAX) Shares - Insider Monkey
Ascites Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company - The Globe and Mail
Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda - Yahoo Finance
Baxter to split into two companies - The Covington News
Morgan Stanley Keeps Sell Rating on Baxter International with $19 Target - AInvest
Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing - Fierce Healthcare
Baxter International (BAX) Is Up 7.9% After Reversing Losses and Reaffirming 2025 Sales Growth Outlook - simplywall.st
UBS Group Cuts Baxter International (NYSE:BAX) Price Target to $24.00 - MarketBeat
Baxter International's GF Score Indicates Potential for Underperformance - AInvest
FDA's IV Shortage Resolution Lifts Baxter's Volume to 394th Rank as Stock Rises 0.64% - AInvest
Barclays Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter International's (BAX) Hold Rating Reiterated at Stifel Nicolaus - MarketBeat
Arkadios Wealth Advisors Acquires Shares of 17,245 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. shares rise 1.98% intraday after ATS Corporation reported Q1 revenue growth and provided Q2 revenue guidance. - AInvest
Baxter International Inc. (NYSE:BAX) Shares Bought by Raiffeisen Bank International AG - MarketBeat
Are Wall Street Analysts Bullish on Baxter International Stock? - MSN
LSV Asset Management Sells 391,800 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International 2025 Q2 Earnings Strong Turnaround as Net Income Surges 129% - AInvest
Baxter International (BAX) Falls to New Low on Disappointing Growth Forecast - MSN
Baxter International Inc. (BAX): A Bull Case Theory - Insider Monkey
Wall Street Zen Downgrades Baxter International (NYSE:BAX) to Hold - MarketBeat
Baxter International Surges 1.78% on $330M Volume Ranking 363rd as Tactical Strategy Outperforms Benchmark by 137.53 Pts - AInvest
Baxter stock rises on earnings beat, guidance raise - MSN
Baxter International (NYSE:BAX) Updates FY 2025 Earnings Guidance - MarketBeat
Baxter International (NYSE:BAX) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Stifel Downgrades Baxter International (BAX) - MSN
Baxter slashes its profit forecast after disappointing quarter - Medical Buyer
Barclays Lowers Price Target on Baxter International to $36 From $41, Maintains Overweight Rating - MarketScreener
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):